Amplification oligonucleotides

US11859244B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11859244-B2
Application numberUS-202318185786-A
CountryUS
Kind codeB2
Filing dateMar 17, 2023
Priority dateSep 3, 2021
Publication dateJan 2, 2024
Grant dateJan 2, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein, inter alia, are polynucleotides, supports, kits, and methods of use thereof for amplifying, immobilizing, and sequencing polynucleotides.

First claim

Opening claim text (preview).

What is claimed is: 1. A kit comprising a first oligonucleotide comprising a first sequencing primer sequence and a second sequencing primer binding sequence; a second oligonucleotide comprising from 5′ to 3′, a first platform primer sequence and a sequence complementary to the first sequencing primer sequence; a third oligonucleotide comprising from 5′ to 3′, a second platform primer sequence and a sequence complementary to the second sequencing primer binding sequence; wherein said first platform primer sequence comprises SEQ ID NO:92; and said second platform primer sequence comprises SEQ ID NO:89. 2. The kit of claim 1 , wherein the first sequencing primer sequence is SEQ ID NO:152. 3. The kit of claim 2 , wherein the second sequencing primer binding sequence is SEQ ID NO:178. 4. The kit of claim 1 , further comprising a solid support. 5. The kit of claim 4 , wherein said solid support is a flow cell, particle, chip, slide, multi-well container, or unpatterned solid support. 6. The kit of claim 4 , wherein said solid support is a multi-well container. 7. The kit of claim 4 , wherein said solid support further comprises two or more wells, wherein each well comprises a first plurality of immobilized oligonucleotides, wherein each oligonucleotide of the first plurality comprises the first platform primer sequence, and a second plurality of immobilized oligonucleotides, wherein each oligonucleotide of the second plurality comprises the second platform primer sequence. 8. The kit of claim 7 , wherein said solid support comprises about 0.2 wells to about 4.0 wells per μm 2 . 9. The kit of claim 7 , wherein each of the wells is separated from each of the other wells by about 0.2 μm to about 2.0 μm. 10. The kit of claim 1 , further comprising a sequencing polymerase, and one or more amplification polymerases. 11. The kit of claim 10 , further comprising a plurality of native deoxynucleotides (dNTPs) and a plurality of modified dNTPs. 12. The kit of claim 11 , wherein said plurality of modified dNTPs comprises a reversible terminator moiety. 13. The kit of claim 1 , wherein said second oligonucleotide, said third oligonucleotide, or both said second and third oligonucleotides further comprise an index sequence. 14. The kit of claim 13 , wherein said index sequence comprises between 8 to 12 nucleotides. 15. The kit of claim 1 , further comprising a polynucleotide adapter, said polynucleotide adapter comprising a first strand comprising a first binding sequence and a first tail sequence; and a second strand comprising a second binding sequence and a second tail sequence, wherein at least a portion of the first binding sequence is hybridized to a portion of the second binding sequence; wherein the first tail sequence comprises SEQ ID NO:5, SEQ ID NO:9, SEQ ID NO:85, SEQ ID NO:92, SEQ ID NO:90, SEQ ID NO:88, SEQ ID NO:117, SEQ ID NO:119, SEQ ID NO:121, or SEQ ID NO:123 and the second tail sequence comprises SEQ ID NO:4, SEQ ID NO:102, SEQ ID NO:104, SEQ ID NO:106, SEQ ID NO:108, SEQ ID NO:134, SEQ ID NO:136, SEQ ID NO:138, or SEQ ID NO:140, and the first binding sequence comprises SEQ ID NO:152 and the second binding sequence comprises SEQ ID NO:178. 16. The kit of claim 15 , wherein the polynucleotide adapter is a Y polynucleotide adapter. 17. The kit of claim 15 , wherein the polynucleotide adapter is a hairpin adapter. 18. The kit of claim 17 , wherein the hairpin adapter comprises a cleavable site. 19. The kit of claim 17 , wherein the first tail sequence is covalently attached to the second tail sequence. 20. A kit comprising: a first oligonucleotide comprising from 5′ to 3′, a first platform primer sequence and a first sequencing primer sequence; a second oligonucleotide comprising from 5′ to 3′, a second platform primer sequence and a second sequencing primer sequence; wherein said first platform primer sequence comprises SEQ ID NO:92; and said second platform primer sequence comprises SEQ ID NO:89. 21. The kit of claim 20 , wherein the first sequencing primer sequence is SEQ ID NO:152.

Assignees

Inventors

Classifications

  • C12Q1/6855Primary

    Ligating adaptors · CPC title

  • involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title

  • Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes · CPC title

  • using probe arrays or probe chips (C12Q1/6874 takes precedence) · CPC title

  • characterised by the manufacture of the container or its components · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11859244B2 cover?
Disclosed herein, inter alia, are polynucleotides, supports, kits, and methods of use thereof for amplifying, immobilizing, and sequencing polynucleotides.
Who is the assignee on this patent?
Singular Genomics Systems Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6855. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).